Target intelligence / Profile preview

Neutrophil-derived oxygen free radicals (None)

Target: None
Molecular classification: Reactive Oxygen Species (ROS), Oxidants

Overview

Neutrophil-derived oxygen free radicals are highly reactive molecules produced by neutrophils, primarily as part of the innate immune response. These radicals play a central role in host defense by killing invading pathogens but can also contribute to tissue damage and inflammation when produced in excess. The main oxygen free radicals generated by neutrophils include superoxide anion, hydrogen peroxide, hydroxyl radical, hypochlorous acid, and singlet oxygen. Overproduction or dysregulation of neutrophil-derived ROS is implicated in various diseases, including acute lung injury, cardiovascular dysfunction, and chronic inflammatory diseases.

Other names: Reactive Oxygen Species (ROS) from NeutrophilsNeutrophil ROSNeutrophil-derived ROS

Mechanism of action

Antioxidant activity; scavenging of free radicals

Biological functions

Pathogen killingModulation of inflammationOxidative stress induction

Disease associations

Acute lung injury/ARDSCardiovascular dysfunctionChronic inflammatory diseasesAtherosclerosisRheumatoid arthritisCancer progression

Safety considerations

Systemic side effects of antioxidantsPotential disruption of normal immune function with broad ROS inhibitionSpecificity of targeted therapies

Interacting drugs

N-acetylcysteine

2 more in the full profile.

Beyond the preview

Go deeper on Neutrophil-derived oxygen free radicals (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil-derived oxygen free radicals (None).

Explore the full profile